346 related articles for article (PubMed ID: 31581251)
21. Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria.
Agrawal V; Prasad N; Jain M; Pandey R
Clin Exp Nephrol; 2013 Dec; 17(6):811-8. PubMed ID: 23377573
[TBL] [Abstract][Full Text] [Related]
22. Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab.
Alachkar N; Li J; Matar D; Vujjini V; Alasfar S; Tracy M; Reiser J; Wei C
BMC Nephrol; 2018 Dec; 19(1):361. PubMed ID: 30558559
[TBL] [Abstract][Full Text] [Related]
23. Pathophysiology of focal segmental glomerulosclerosis.
Reidy K; Kaskel FJ
Pediatr Nephrol; 2007 Mar; 22(3):350-4. PubMed ID: 17216262
[TBL] [Abstract][Full Text] [Related]
24. Podocyte Wnt/ß-catenin pathway is activated by integrin-linked kinase in clinical and experimental focal segmental glomerulosclerosis.
Naves MA; Requião-Moura LR; Soares MF; Silva-Júnior JA; Mastroianni-Kirsztajn G; Teixeira VP
J Nephrol; 2012; 25(3):401-9. PubMed ID: 21928230
[TBL] [Abstract][Full Text] [Related]
25. Podocyte RNA sequencing reveals Wnt- and ECM-associated genes as central in FSGS.
Bukosza EN; Kratochwill K; Kornauth C; Schachner H; Aufricht C; Gebeshuber CA
PLoS One; 2020; 15(4):e0231898. PubMed ID: 32302353
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical expression of podocyte markers in the variants of focal segmental glomerulosclerosis.
Testagrossa L; Azevedo Neto R; Resende A; Woronik V; Malheiros D
Nephrol Dial Transplant; 2013 Jan; 28(1):91-8. PubMed ID: 22859792
[TBL] [Abstract][Full Text] [Related]
27. Development of a novel cell-based assay to diagnose recurrent focal segmental glomerulosclerosis patients.
Srivastava P; Solanki AK; Arif E; Wolf BJ; Janech MG; Budisavljevic MN; Kwon SH; Nihalani D
Kidney Int; 2019 Mar; 95(3):708-716. PubMed ID: 30709661
[TBL] [Abstract][Full Text] [Related]
28. The parietal epithelial cell is crucially involved in human idiopathic focal segmental glomerulosclerosis.
Dijkman H; Smeets B; van der Laak J; Steenbergen E; Wetzels J
Kidney Int; 2005 Oct; 68(4):1562-72. PubMed ID: 16164633
[TBL] [Abstract][Full Text] [Related]
29. Focal Segmental Glomerulosclerosis.
Rosenberg AZ; Kopp JB
Clin J Am Soc Nephrol; 2017 Mar; 12(3):502-517. PubMed ID: 28242845
[TBL] [Abstract][Full Text] [Related]
30. Nuclear exclusion of YAP exacerbates podocyte apoptosis and disease progression in Adriamycin-induced focal segmental glomerulosclerosis.
Zhuang Q; Li F; Liu J; Wang H; Tian Y; Zhang Z; Wang F; Zhao Z; Chen J; Wu H
Lab Invest; 2021 Feb; 101(2):258-270. PubMed ID: 33203894
[TBL] [Abstract][Full Text] [Related]
31. Glomerular hypertrophy precedes albuminuria and segmental loss of podoplanin in podocytes in Munich-Wistar-Frömter rats.
Ijpelaar DH; Schulz A; Koop K; Schlesener M; Bruijn JA; Kerjaschki D; Kreutz R; de Heer E
Am J Physiol Renal Physiol; 2008 Apr; 294(4):F758-67. PubMed ID: 18199599
[TBL] [Abstract][Full Text] [Related]
32. OPN deficiency results in severe glomerulosclerosis in uninephrectomized mice.
Schordan S; Grisk O; Schordan E; Miehe B; Rumpel E; Endlich K; Giebel J; Endlich N
Am J Physiol Renal Physiol; 2013 Jun; 304(12):F1458-70. PubMed ID: 23552865
[TBL] [Abstract][Full Text] [Related]
33. Blocking ribosomal protein S6 phosphorylation inhibits podocyte hypertrophy and focal segmental glomerulosclerosis.
Li F; Fang Y; Zhuang Q; Cheng M; Moronge D; Jue H; Meyuhas O; Ding X; Zhang Z; Chen JK; Wu H
Kidney Int; 2022 Jul; 102(1):121-135. PubMed ID: 35483522
[TBL] [Abstract][Full Text] [Related]
34. Soluble urokinase receptor and focal segmental glomerulosclerosis.
Reiser J; Wei C; Tumlin J
Curr Opin Nephrol Hypertens; 2012 Jul; 21(4):428-32. PubMed ID: 22569341
[TBL] [Abstract][Full Text] [Related]
35. A molecular profile of focal segmental glomerulosclerosis from formalin-fixed, paraffin-embedded tissue.
Hodgin JB; Borczuk AC; Nasr SH; Markowitz GS; Nair V; Martini S; Eichinger F; Vining C; Berthier CC; Kretzler M; D'Agati VD
Am J Pathol; 2010 Oct; 177(4):1674-86. PubMed ID: 20847290
[TBL] [Abstract][Full Text] [Related]
36. Podocyte protease activated receptor 1 stimulation in mice produces focal segmental glomerulosclerosis mirroring human disease signaling events.
May CJ; Chesor M; Hunter SE; Hayes B; Barr R; Roberts T; Barrington FA; Farmer L; Ni L; Jackson M; Snethen H; Tavakolidakhrabadi N; Goldstone M; Gilbert R; Beesley M; Lennon R; Foster R; Coward R; Welsh GI; Saleem MA
Kidney Int; 2023 Aug; 104(2):265-278. PubMed ID: 36940798
[TBL] [Abstract][Full Text] [Related]
37. Focal segmental glomerulosclerosis and renal transplantation.
Crosson JT
Transplant Proc; 2007 Apr; 39(3):737-43. PubMed ID: 17445586
[TBL] [Abstract][Full Text] [Related]
38. Loss of the podocyte-expressed transcription factor Tcf21/Pod1 results in podocyte differentiation defects and FSGS.
Maezawa Y; Onay T; Scott RP; Keir LS; Dimke H; Li C; Eremina V; Maezawa Y; Jeansson M; Shan J; Binnie M; Lewin M; Ghosh A; Miner JH; Vainio SJ; Quaggin SE
J Am Soc Nephrol; 2014 Nov; 25(11):2459-70. PubMed ID: 24904088
[TBL] [Abstract][Full Text] [Related]
39. Podocyte injury at young age causes premature senescence and worsens glomerular aging.
Veloso Pereira BM; Zeng Y; Maggiore JC; Schweickart RA; Eng DG; Kaverina N; McKinzie SR; Chang A; Loretz CJ; Thieme K; Hukriede NA; Pippin JW; Wessely O; Shankland SJ
Am J Physiol Renal Physiol; 2024 Jan; 326(1):F120-F134. PubMed ID: 37855038
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease.
Lee HS
Cell Tissue Res; 2012 Jan; 347(1):129-40. PubMed ID: 21541658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
